Psychologic disorders and statin use: A propensity score-matched analysis

Ishak Mansi, Christopher R. Frei, Mary J. Pugh, Eric M. Mortensen

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

STUDY OBJECTIVE To evaluate the association between statin therapy and the risk of psychologic disorders including schizophrenia, psychosis, major depression, and bipolar disorder in a military population. DESIGN Retrospective, observational, population-based, propensity score-matched, cohort study. SETTING Database of a patient population enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus. PATIENTS Medical records were reviewed from 46,249 patients aged 30-85 years who were continuously enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus from October 1, 2003- March 1, 2010. Data were obtained from the Military Health System Management Analysis and Reporting Tool (M2). Based on drug fills during fiscal year 2005, patients were stratified as statin users (13,626 patients received at least 90-days supply of statin) or nonusers (32,623 patients never received a statin during the study period). A propensity score-matched cohort of 6972 statin users and 6972 nonusers from this population was created. MEASUREMENTS AND MAIN RESULTS The occurrence of psychologic disorders between October 1, 2005, and March 1, 2010, was determined using prespecified groups of ICD-9-CM, Psych1: schizophrenia, schizoaffective disorders, and other psychosis; Psych2: major depression and bipolar disorder; Psych3: all psychologic disorders as identified by the Agency for Health Research and Quality-Clinical Classifications (except for categories of childhood or developmental psychiatric disorders). Between matched pairs of statin users and nonusers, the odds ratios and 95% confidence intervals were as follows: Psych1 (0.9, 0.75-1.05), Psych2 (1.02, 0.94-1.11), and Psych3 (1.02, 0.96-1.1), respectively. CONCLUSION The risk of developing psychologic disorders was similar in this cohort of propensity score-matched statin users and nonusers.

Original languageEnglish (US)
Pages (from-to)615-626
Number of pages12
JournalPharmacotherapy
Volume33
Issue number6
DOIs
StatePublished - Jun 2013

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Propensity Score
Psychotic Disorders
Bipolar Disorder
Population
Schizophrenia
Depression
Health
International Classification of Diseases
Medical Records
Psychiatry
Cohort Studies
Odds Ratio
Databases
Confidence Intervals
Research
Pharmaceutical Preparations

Keywords

  • Adverse events
  • Depression
  • Observational study
  • Psychological injury
  • Schizophrenia
  • Statin

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Psychologic disorders and statin use : A propensity score-matched analysis. / Mansi, Ishak; Frei, Christopher R.; Pugh, Mary J.; Mortensen, Eric M.

In: Pharmacotherapy, Vol. 33, No. 6, 06.2013, p. 615-626.

Research output: Contribution to journalArticle

Mansi, Ishak ; Frei, Christopher R. ; Pugh, Mary J. ; Mortensen, Eric M. / Psychologic disorders and statin use : A propensity score-matched analysis. In: Pharmacotherapy. 2013 ; Vol. 33, No. 6. pp. 615-626.
@article{633bac3ab11b485d983286ab0f109461,
title = "Psychologic disorders and statin use: A propensity score-matched analysis",
abstract = "STUDY OBJECTIVE To evaluate the association between statin therapy and the risk of psychologic disorders including schizophrenia, psychosis, major depression, and bipolar disorder in a military population. DESIGN Retrospective, observational, population-based, propensity score-matched, cohort study. SETTING Database of a patient population enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus. PATIENTS Medical records were reviewed from 46,249 patients aged 30-85 years who were continuously enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus from October 1, 2003- March 1, 2010. Data were obtained from the Military Health System Management Analysis and Reporting Tool (M2). Based on drug fills during fiscal year 2005, patients were stratified as statin users (13,626 patients received at least 90-days supply of statin) or nonusers (32,623 patients never received a statin during the study period). A propensity score-matched cohort of 6972 statin users and 6972 nonusers from this population was created. MEASUREMENTS AND MAIN RESULTS The occurrence of psychologic disorders between October 1, 2005, and March 1, 2010, was determined using prespecified groups of ICD-9-CM, Psych1: schizophrenia, schizoaffective disorders, and other psychosis; Psych2: major depression and bipolar disorder; Psych3: all psychologic disorders as identified by the Agency for Health Research and Quality-Clinical Classifications (except for categories of childhood or developmental psychiatric disorders). Between matched pairs of statin users and nonusers, the odds ratios and 95{\%} confidence intervals were as follows: Psych1 (0.9, 0.75-1.05), Psych2 (1.02, 0.94-1.11), and Psych3 (1.02, 0.96-1.1), respectively. CONCLUSION The risk of developing psychologic disorders was similar in this cohort of propensity score-matched statin users and nonusers.",
keywords = "Adverse events, Depression, Observational study, Psychological injury, Schizophrenia, Statin",
author = "Ishak Mansi and Frei, {Christopher R.} and Pugh, {Mary J.} and Mortensen, {Eric M.}",
year = "2013",
month = "6",
doi = "10.1002/phar.1272",
language = "English (US)",
volume = "33",
pages = "615--626",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "6",

}

TY - JOUR

T1 - Psychologic disorders and statin use

T2 - A propensity score-matched analysis

AU - Mansi, Ishak

AU - Frei, Christopher R.

AU - Pugh, Mary J.

AU - Mortensen, Eric M.

PY - 2013/6

Y1 - 2013/6

N2 - STUDY OBJECTIVE To evaluate the association between statin therapy and the risk of psychologic disorders including schizophrenia, psychosis, major depression, and bipolar disorder in a military population. DESIGN Retrospective, observational, population-based, propensity score-matched, cohort study. SETTING Database of a patient population enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus. PATIENTS Medical records were reviewed from 46,249 patients aged 30-85 years who were continuously enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus from October 1, 2003- March 1, 2010. Data were obtained from the Military Health System Management Analysis and Reporting Tool (M2). Based on drug fills during fiscal year 2005, patients were stratified as statin users (13,626 patients received at least 90-days supply of statin) or nonusers (32,623 patients never received a statin during the study period). A propensity score-matched cohort of 6972 statin users and 6972 nonusers from this population was created. MEASUREMENTS AND MAIN RESULTS The occurrence of psychologic disorders between October 1, 2005, and March 1, 2010, was determined using prespecified groups of ICD-9-CM, Psych1: schizophrenia, schizoaffective disorders, and other psychosis; Psych2: major depression and bipolar disorder; Psych3: all psychologic disorders as identified by the Agency for Health Research and Quality-Clinical Classifications (except for categories of childhood or developmental psychiatric disorders). Between matched pairs of statin users and nonusers, the odds ratios and 95% confidence intervals were as follows: Psych1 (0.9, 0.75-1.05), Psych2 (1.02, 0.94-1.11), and Psych3 (1.02, 0.96-1.1), respectively. CONCLUSION The risk of developing psychologic disorders was similar in this cohort of propensity score-matched statin users and nonusers.

AB - STUDY OBJECTIVE To evaluate the association between statin therapy and the risk of psychologic disorders including schizophrenia, psychosis, major depression, and bipolar disorder in a military population. DESIGN Retrospective, observational, population-based, propensity score-matched, cohort study. SETTING Database of a patient population enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus. PATIENTS Medical records were reviewed from 46,249 patients aged 30-85 years who were continuously enrolled in the San Antonio Military Multi-Market Area as Tricare Prime or Plus from October 1, 2003- March 1, 2010. Data were obtained from the Military Health System Management Analysis and Reporting Tool (M2). Based on drug fills during fiscal year 2005, patients were stratified as statin users (13,626 patients received at least 90-days supply of statin) or nonusers (32,623 patients never received a statin during the study period). A propensity score-matched cohort of 6972 statin users and 6972 nonusers from this population was created. MEASUREMENTS AND MAIN RESULTS The occurrence of psychologic disorders between October 1, 2005, and March 1, 2010, was determined using prespecified groups of ICD-9-CM, Psych1: schizophrenia, schizoaffective disorders, and other psychosis; Psych2: major depression and bipolar disorder; Psych3: all psychologic disorders as identified by the Agency for Health Research and Quality-Clinical Classifications (except for categories of childhood or developmental psychiatric disorders). Between matched pairs of statin users and nonusers, the odds ratios and 95% confidence intervals were as follows: Psych1 (0.9, 0.75-1.05), Psych2 (1.02, 0.94-1.11), and Psych3 (1.02, 0.96-1.1), respectively. CONCLUSION The risk of developing psychologic disorders was similar in this cohort of propensity score-matched statin users and nonusers.

KW - Adverse events

KW - Depression

KW - Observational study

KW - Psychological injury

KW - Schizophrenia

KW - Statin

UR - http://www.scopus.com/inward/record.url?scp=84879560627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879560627&partnerID=8YFLogxK

U2 - 10.1002/phar.1272

DO - 10.1002/phar.1272

M3 - Article

C2 - 23625731

AN - SCOPUS:84879560627

VL - 33

SP - 615

EP - 626

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 6

ER -